News

BioSpace6h
Regeneron Backs Off 23andMe, Losing Bid to Former CEO
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...
Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm
Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...
Anne Wojcicki’s nonprofit reaches deal to acquire 23andMe
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...
Regeneron CEO on 23andMe bid: Trying to balance individual privacy with biotech & genetics research
Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, ...
Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
Lohud.com, Westchester County on MSN4d
NY sues 23andMe to block sale of your genetic data to the highest bidder. What to know
New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...
Almost 2 million 23andMe users have asked the company to delete their data in the last 2 months
Me's Interim CEO Joe Selsavage said 1.9 million customers have asked the company delete their data since March.
STAT4d
23andMe leaders grilled on genetic data risks by federal lawmakers
The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.